Glycemic control is another target of PCI in diabetic patients: To improve clinical outcome from outside the procedure

Circulation Journal

Volumn 75, Issue 4, 2011, Pages 773-774

  Fujita, Hideo ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; DYSLIPIDEMIA; EDITORIAL; GLYCEMIC CONTROL; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; LIFE EXPECTANCY; OFF PUMP CORONARY SURGERY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; THROMBOPHILIA;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 79953658926     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1255     Document Type: Editorial

References (15)

1. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 2008; 52: 1957-1967.
2. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010; 55: 432-440.
3. Yamagata K, Kataoka Y, Kokubu N, Kasahara Y, Abe M, Nakajima H, et al. A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 2010; 74: 671-678.
4. Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: A report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2004; 109: 476-480.
5. Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: Indirect comparison of controlled trials. Heart 2006; 92: 650-657.
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
7. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
8. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
9. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
10. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA 2005; 293: 1501-1508.
11. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004; 43: 8-14.
12. Hage C, Norhammar A, Grip L, Malmberg K, Sarkar N, Svane B, et al. Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: A report from the Insulin Diabetes Angioplasty study. Diabet Vasc Dis Res 2009; 6: 71-79.
13. Ike A, Nishikawa H, Shirai K, Mori K, Kuwano T, Fukuda Y, et al. Impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention: From the FURegistry. Circ J 2011; 75: 791-799.
14. Association AD. Standards of medical care in diabetes: 2010. Diabetes Care 2010; 33: S11-S61.
15. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-2372.